Market Overview

Boston Scientific Buys Rhythmia Medical; Sees Immaterial in FY13 and FY14

Related BSX
St. Jude Medical Hits New Lifetime High - Analyst Blog
Wall Street Comfortable With Covidien Buy; Some See Move By Johnson & Johnson

Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.  Rhythmia Medical is based in Burlington, MA.  The transaction is expected to close by Friday, October 12^th.

Posted-In: News M&A

 

Most Popular

Related Articles (BSX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free